ANZ, ResMed Inc and Macquarie Group Ltd: Should you buy?

These well-known blue-chip stocks could hold value at today's prices.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Australia and New Zealand Banking Group (ASX: ANZ), ResMed Inc. (CHESS) (ASX: RMD) and Macquarie Group Ltd (ASX: MQG) are setting the world on fire with first-class growth strategies. While some Australian companies, such as National Australia Bank Ltd. (ASX: NAB) and Insurance Australia Group Limited (ASX: IAG), have been hindered by poorly conceived international expansions.

However, the former's success hasn't gone unnoticed by the market. Shares in ANZ, ResMed and Macquarie are up 44%, 68% and 127%, respectively in the past two years not including dividends. So are they still a buy at today's prices? Or will they struggle to beat the S&P/ASX 200 Index (ASX: XJO) (INDEX: ^AXJO) from here?

Here's what I think you can expect from these three successful Australian companies in coming years.

ANZ

ANZ has, since 2007, been implementing its Super Regional Strategy which is unique amongst Australia's banks because it will actively compete with other banks in Asia. Its International and Institutional Banking division continues to perform strongly as its customer base in the region expands. Locally ANZ has committed to increasing its mortgage market exposure and business banking.

Despite the obvious growth prospects, I don't believe now is a good time to buy ANZ shares (or any of the big banks for that matter). I'd rather wait for a pullback in price before committing to an investment.

ResMed

With increased awareness for sleep related respiratory disorders, the customer base for ResMed's world-class products is growing. This trend looks set to continue for many years. Although ResMed has grown into a $7.3 billion company, which means its growth will now be off a larger base and therefore slower, it trades at a reasonable price given its exceptional long-term prospects. Dividends will also increase in coming years.

Macquarie

As our largest investment bank, Macquarie stands out as an obvious beneficiary of rallying stock markets and improving confidence throughout the world. With 68% of income derived from international markets, a conservative balance sheet and growing funds under management, Macquarie appears to be a compelling long-term buy to hold.

A BETTER ASX stock idea than these 3 – FREE!

Of these three companies, I'd buy ResMed first. Whilst I feel both Macquarie and ANZ have promising futures, their current share prices don't scream "bargain" to me. However with over 2,000 companies on the ASX, you shouldn't limit yourself to just three. Shop around a bit!

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any of the mentioned companies. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »